The investment management industry is making headlines yet again, with Confluence Investment Management LLC raising its position in shares of Crescent Capital BDC, Inc. by a whopping 36.4% during the first quarter of the year. According to its recent filing with the Securities & Exchange Commission, the company acquired an additional 17,983 shares during this period and now boasts a holding of 67,436 shares. This brings their total ownership up to approximately 0.22% of Crescent Capital BDC.
For those not in the know, Crescent Capital BDC is classified as a business development company private equity / buyouts and loan fund that specializes in directly investing. It focuses on middle market opportunities within the United States and has garnered quite a bit of attention from investors over the past year.
Shares of Crescent Capital BDC opened at $14.50 on Monday, further solidifying its worth as a viable investment opportunity for patrons looking to diversify their portfolios. The firm currently holds a debt-to-equity ratio of 1.22 and a current ratio of 1.58 with a quick ratio that mirrors it exactly – a strong indication of financial stability within its operations.
Despite having faced both peaks and valleys over the past year – experiencing both a low point at $12.55 and high point at $18.19 – Crescent Capital BDC is still very much on investors’ radars across the country today.
Furthermore, with Confluence Investment Management LLC taking such an ambitious step to increase its position in this particular enterprise, it draws focus towards just how worth considering Crescent Capital BDC has become for prospective investors seeking long-term gains.
With all these pointers in mind, one can see why many experts continue to view companies like Crescent Capital BDC as an essential source for any eyes lurking for strategic investments that can last significantly longer than just weeks or months – even years later down the line when changes occur throughout varying fiscal quarters.
[bs_slider_forecast ticker=”CCAP”]
Crescent Capital BDC: A Closer Look at Investor Interest and Performance
Crescent Capital BDC: What Investors Need to Know
Crescent Capital BDC, Inc. (CCAP) is a business development private equity and loan fund that specializes in middle market direct investments in the United States. As of June 19, 2023, institutional investors owned approximately 36.62% of the company’s stock. The fund has caught the attention of multiple hedge funds lately.
Captrust Financial Advisors grew its holdings in shares of Crescent Capital BDC by 3.7% in the fourth quarter and now owns over 63,000 shares worth $808,000 after purchasing an additional 2,250 shares during the last quarter.
Millennium Management LLC also bought a new position in shares of Crescent Capital BDC in the fourth quarter worth about $1,144,000.
Mariner LLC grew its holdings in CCAP by 4.5% during Q4 and now owns over 685,618 shares worth approximately $8,762,000 after purchasing an additional 29,735 shares during the same quarter.
Ares Management LLC increased its stake by about 5% during Q4 with over 522k shares worth approximately $6.7M acquired after purchasing an additional 25k Shares.
Lastly, Almitas Captial Banking on CCAP’s potential bought new positions worth around $14 million in Q4.
In addition to recent trends among hedge funds towards CCAP’s stock interest from research analysts have been stirring up buzz as well. TheStreet upgraded Crescent Capital BDC from a “c” rating to a “b-” rating back on Monday, March 20th while Oppenheimer dropped their target price on Crescent Capital BDC from $19 down to $18 with an “outperform” rating on the stock— doing so within days of each other back at the end of February.
Despite analyst opinions regarding CCAP though it’s essential to focus on the facts surrounding the company’s performance. The company had released its quarterly earnings results back on May 10th, reporting $0.54 EPS for the quarter, roughly $0.07 higher than consensus estimates of an EPS of $0.47. Revenue was reported to be over $39 million during Q1 compared to analyst expectations of $35.85 million— reflecting a growth rate of over 6%., furthermore CCAP maintained a net margin of 5.49% and a return on equity of 8.98%.
More recently, the company declared a quarterly dividend, earmarking its payment date for Monday, July 17th with shareholders who held stock from Friday, June 30th receiving a dividend payout of $0.41 per share—an annualized total of $1.64 per share with an estimated yield per payout at around 11.31%.Â
As always, investors should be vigilant when it comes to making informed investment decisions given all relevant information available as analysis can never guarantee future returns nor trends in financial markets; however, focusing on key statistics and facts can improve one’s understanding of market dynamics and shifts in investor interest like those regarding Crescent Capital BDC Inc.’s recent spikes in interest from hedge funds and fluctuations in past stock ratings by research analysts concerned with CCAP’s trajectory going forward.